<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>Bella Smith's show</title><link>https://www.spreaker.com/show/bella-smiths-show_2</link><description><![CDATA[]]></description><atom:link href="https://www.spreaker.com/show/2498337/episodes/feed" rel="self" type="application/rss+xml"/><language>zh</language><category>Society &amp; Culture</category><copyright>Copyright Bella Smith</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg</url><title>Bella Smith's show</title><link>https://www.spreaker.com/show/bella-smiths-show_2</link></image><lastBuildDate>Wed, 16 Aug 2017 07:50:41 +0000</lastBuildDate><itunes:author>Bella Smith</itunes:author><itunes:owner><itunes:name>Bella Smith</itunes:name><itunes:email>feeds@spreaker.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:category text="Society &amp; Culture"/><itunes:explicit>clean</itunes:explicit><itunes:type>episodic</itunes:type><googleplay:author>Bella Smith</googleplay:author><googleplay:email>feeds@spreaker.com</googleplay:email><googleplay:category text="Society &amp; Culture"/><googleplay:explicit>No</googleplay:explicit><item><title>high affinity antibody</title><link>https://www.spreaker.com/user/9880356/high-affinity-antibody</link><description><![CDATA[Human monoclonal antibody (mAbs) are emerging in the field of cancer therapy and have become an increasing proportion of new drugs that are recently approved. Although there are some methods to obtain antigen-specific mAbs from human B cells, it is generally impossible to directly immunize human beings with antigens of interest. For example, for infectious agents, those approaches are largely restricted. To solve these obstacles, two main approaches have been developed; either by humanizing antigen-specific antibodies from small experimental animals (which is laborious due to the great genetic differences from humans) or rely on the in vitro selection of antigen-specific binders from human antibody repertoires. However, the human mAbs developed by these methods are usually with low affinity.<br /><br /><a href="http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html" rel="noopener">http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12585832</guid><pubDate>Wed, 16 Aug 2017 07:50:41 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12585832/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Human monoclonal antibody (mAbs) are emerging in the field of cancer therapy and have become an increasing proportion of new drugs that are recently approved. Although there are some methods to obtain antigen-specific mAbs from human B cells, it is...</itunes:subtitle><itunes:summary><![CDATA[Human monoclonal antibody (mAbs) are emerging in the field of cancer therapy and have become an increasing proportion of new drugs that are recently approved. Although there are some methods to obtain antigen-specific mAbs from human B cells, it is generally impossible to directly immunize human beings with antigens of interest. For example, for infectious agents, those approaches are largely restricted. To solve these obstacles, two main approaches have been developed; either by humanizing antigen-specific antibodies from small experimental animals (which is laborious due to the great genetic differences from humans) or rely on the in vitro selection of antigen-specific binders from human antibody repertoires. However, the human mAbs developed by these methods are usually with low affinity.<br /><br /><a href="http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html" rel="noopener">http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotech,biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Human monoclonal antibody (mAbs) are emerging in the field of cancer therapy and have become an increasing proportion of new drugs that are recently approved. Although there are some methods to obtain antigen-specific mAbs from human B cells, it is generally impossible to directly immunize human beings with antigens of interest. For example, for infectious agents, those approaches are largely restricted. To solve these obstacles, two main approaches have been developed; either by humanizing antigen-specific antibodies from small experimental animals (which is laborious due to the great genetic differences from humans) or rely on the in vitro selection of antigen-specific binders from human antibody repertoires. However, the human mAbs developed by these methods are usually with low affinity.

http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>transgenic mice antibody production</title><link>https://www.spreaker.com/user/9880356/transgenic-mice-antibody-production</link><description><![CDATA[By introducing human immunoglobulin loci (heavy and light chains) into the mouse germlines with inactivated/disrupted endogenous antibody machinery, the transgenic mouse/rat strains can directly generate high affinity, fully human antibodies, which avoid the subsequent costly and tedious in vitro humanization and affinity maturation process. Upon immunization, the Ig transgenes will undergo V(D)J rearrangement, random nucleotide (N region) addition, class switching, and somatic hypermutation to yield impeccable antibodies. This technology takes advantage of the naturally intact immune system with robust response, high-efficient selection and in vivo maturation while maintaining fully humanness which can eliminate immunogenicity concerns.<br /><br /><a href="http://www.creative-biolabs.com/Human-Antibody-Production-from-Transgenic-Mice.html" rel="noopener">http://www.creative-biolabs.com/Human-Antibody-Production-from-Transgenic-Mice.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12585787</guid><pubDate>Wed, 16 Aug 2017 07:43:24 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12585787/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>By introducing human immunoglobulin loci (heavy and light chains) into the mouse germlines with inactivated/disrupted endogenous antibody machinery, the transgenic mouse/rat strains can directly generate high affinity, fully human antibodies, which...</itunes:subtitle><itunes:summary><![CDATA[By introducing human immunoglobulin loci (heavy and light chains) into the mouse germlines with inactivated/disrupted endogenous antibody machinery, the transgenic mouse/rat strains can directly generate high affinity, fully human antibodies, which avoid the subsequent costly and tedious in vitro humanization and affinity maturation process. Upon immunization, the Ig transgenes will undergo V(D)J rearrangement, random nucleotide (N region) addition, class switching, and somatic hypermutation to yield impeccable antibodies. This technology takes advantage of the naturally intact immune system with robust response, high-efficient selection and in vivo maturation while maintaining fully humanness which can eliminate immunogenicity concerns.<br /><br /><a href="http://www.creative-biolabs.com/Human-Antibody-Production-from-Transgenic-Mice.html" rel="noopener">http://www.creative-biolabs.com/Human-Antibody-Production-from-Transgenic-Mice.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotech,biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>By introducing human immunoglobulin loci (heavy and light chains) into the mouse germlines with inactivated/disrupted endogenous antibody machinery, the transgenic mouse/rat strains can directly generate high affinity, fully human antibodies, which avoid the subsequent costly and tedious in vitro humanization and affinity maturation process. Upon immunization, the Ig transgenes will undergo V(D)J rearrangement, random nucleotide (N region) addition, class switching, and somatic hypermutation to yield impeccable antibodies. This technology takes advantage of the naturally intact immune system with robust response, high-efficient selection and in vivo maturation while maintaining fully humanness which can eliminate immunogenicity concerns.

http://www.creative-biolabs.com/Human-Antibody-Production-from-Transgenic-Mice.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>tumor targeting</title><link>https://www.spreaker.com/user/9880356/tumor-targeting</link><description><![CDATA[Neoangiogenesis is very important for tumor development. Both blood and lymphatic vessels of tumor express unique markers that distinguish them from normal tissue vasculatures. According to the vascular heterogeneity and changed microenvironment, tumor vasculatures show multiple alterations and differences with regular tissue vasculatures, such as abnormal vessel wall structures, leakiness to macromolecules and constant formation and/or remodeling of vessels. Relevant studies have shown that the endothelial cells of tumor are involved in the variable expression of cell surface molecules by expressing a stimulated phenotype. <br /><br /><a href="http://www.creative-biolabs.com/In-vivo-Phage-Display-for-Tumor-Targeting.htm" rel="noopener">http://www.creative-biolabs.com/In-vivo-Phage-Display-for-Tumor-Targeting.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12585777</guid><pubDate>Wed, 16 Aug 2017 07:40:22 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12585777/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Neoangiogenesis is very important for tumor development. Both blood and lymphatic vessels of tumor express unique markers that distinguish them from normal tissue vasculatures. According to the vascular heterogeneity and changed microenvironment,...</itunes:subtitle><itunes:summary><![CDATA[Neoangiogenesis is very important for tumor development. Both blood and lymphatic vessels of tumor express unique markers that distinguish them from normal tissue vasculatures. According to the vascular heterogeneity and changed microenvironment, tumor vasculatures show multiple alterations and differences with regular tissue vasculatures, such as abnormal vessel wall structures, leakiness to macromolecules and constant formation and/or remodeling of vessels. Relevant studies have shown that the endothelial cells of tumor are involved in the variable expression of cell surface molecules by expressing a stimulated phenotype. <br /><br /><a href="http://www.creative-biolabs.com/In-vivo-Phage-Display-for-Tumor-Targeting.htm" rel="noopener">http://www.creative-biolabs.com/In-vivo-Phage-Display-for-Tumor-Targeting.htm</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>biotech,biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Neoangiogenesis is very important for tumor development. Both blood and lymphatic vessels of tumor express unique markers that distinguish them from normal tissue vasculatures. According to the vascular heterogeneity and changed microenvironment, tumor vasculatures show multiple alterations and differences with regular tissue vasculatures, such as abnormal vessel wall structures, leakiness to macromolecules and constant formation and/or remodeling of vessels. Relevant studies have shown that the endothelial cells of tumor are involved in the variable expression of cell surface molecules by expressing a stimulated phenotype. 

http://www.creative-biolabs.com/In-vivo-Phage-Display-for-Tumor-Targeting.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>in vivo phage display</title><link>https://www.spreaker.com/user/9880356/in-vivo-phage-display</link><description><![CDATA[In vivo phage display is a unique high-throughput method for biopanning by which the peptide phage libraries are directly injected into animals for isolating and identifying the phages bound to specific tissues. Compared with other panning methods, the targets used for isolating phage-displayed peptides are more “intact” with the natural molecular structure and are in the functional states in vivo. Those selected peptides can be used as selective protein transduction domains (PTD) or cell-penetrating peptides (CPPs) for transporting chemotherapeutic agents to the specific tissue, thus improving drug specificity and efficacy in reducing toxicity. Furthermore, some selected peptides can block the function of their ligand proteins by themselves. Using this method, we can offer the functional analysis of new receptors and potential identification and development of novel drug target candidates for the customers.<br /><br /><a href="http://www.creative-biolabs.com/In-vivo-Phage-Display-Service.htm" rel="noopener">http://www.creative-biolabs.com/In-vivo-Phage-Display-Service.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12585769</guid><pubDate>Wed, 16 Aug 2017 07:36:04 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12585769/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>In vivo phage display is a unique high-throughput method for biopanning by which the peptide phage libraries are directly injected into animals for isolating and identifying the phages bound to specific tissues. Compared with other panning methods,...</itunes:subtitle><itunes:summary><![CDATA[In vivo phage display is a unique high-throughput method for biopanning by which the peptide phage libraries are directly injected into animals for isolating and identifying the phages bound to specific tissues. Compared with other panning methods, the targets used for isolating phage-displayed peptides are more “intact” with the natural molecular structure and are in the functional states in vivo. Those selected peptides can be used as selective protein transduction domains (PTD) or cell-penetrating peptides (CPPs) for transporting chemotherapeutic agents to the specific tissue, thus improving drug specificity and efficacy in reducing toxicity. Furthermore, some selected peptides can block the function of their ligand proteins by themselves. Using this method, we can offer the functional analysis of new receptors and potential identification and development of novel drug target candidates for the customers.<br /><br /><a href="http://www.creative-biolabs.com/In-vivo-Phage-Display-Service.htm" rel="noopener">http://www.creative-biolabs.com/In-vivo-Phage-Display-Service.htm</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotech,biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>In vivo phage display is a unique high-throughput method for biopanning by which the peptide phage libraries are directly injected into animals for isolating and identifying the phages bound to specific tissues. Compared with other panning methods, the targets used for isolating phage-displayed peptides are more “intact” with the natural molecular structure and are in the functional states in vivo. Those selected peptides can be used as selective protein transduction domains (PTD) or cell-penetrating peptides (CPPs) for transporting chemotherapeutic agents to the specific tissue, thus improving drug specificity and efficacy in reducing toxicity. Furthermore, some selected peptides can block the function of their ligand proteins by themselves. Using this method, we can offer the functional analysis of new receptors and potential identification and development of novel drug target candidates for the customers.

http://www.creative-biolabs.com/In-vivo-Phage-Display-Service.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>shark mab</title><link>https://www.spreaker.com/user/9880356/shark-mab</link><description><![CDATA[The cartilaginous fishes are known as the oldest phylogenetic group from evolutionary perspective in which possess a “modern” human-type adaptive immune system and immunoglobulins. As one typical species in this family, sharks have been around for over 500 million years. Due to survive in marine environment, large quantities of urea are contained in sharks’ blood to prevent dehydration, while also make their antibodies much more robust than that of other vertebrates. Comparing with the various immunoglobulin isotypes produced by other species, sharks, on the other hand, mainly produce IgM, IgW and IgNAR (immunoglobulin new antigen receptor). IgNAR is a heavy chain homodimer, which consists of five constant domains and one variable region (VNAR) for each heavy chain.<br /><br /><a href="http://www.creative-biolabs.com/Monoclonal-Shark-Antibody-Production.html" rel="noopener">http://www.creative-biolabs.com/Monoclonal-Shark-Antibody-Production.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12585764</guid><pubDate>Wed, 16 Aug 2017 07:34:09 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12585764/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>The cartilaginous fishes are known as the oldest phylogenetic group from evolutionary perspective in which possess a “modern” human-type adaptive immune system and immunoglobulins. As one typical species in this family, sharks have been around for...</itunes:subtitle><itunes:summary><![CDATA[The cartilaginous fishes are known as the oldest phylogenetic group from evolutionary perspective in which possess a “modern” human-type adaptive immune system and immunoglobulins. As one typical species in this family, sharks have been around for over 500 million years. Due to survive in marine environment, large quantities of urea are contained in sharks’ blood to prevent dehydration, while also make their antibodies much more robust than that of other vertebrates. Comparing with the various immunoglobulin isotypes produced by other species, sharks, on the other hand, mainly produce IgM, IgW and IgNAR (immunoglobulin new antigen receptor). IgNAR is a heavy chain homodimer, which consists of five constant domains and one variable region (VNAR) for each heavy chain.<br /><br /><a href="http://www.creative-biolabs.com/Monoclonal-Shark-Antibody-Production.html" rel="noopener">http://www.creative-biolabs.com/Monoclonal-Shark-Antibody-Production.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotech,biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>The cartilaginous fishes are known as the oldest phylogenetic group from evolutionary perspective in which possess a “modern” human-type adaptive immune system and immunoglobulins. As one typical species in this family, sharks have been around for over 500 million years. Due to survive in marine environment, large quantities of urea are contained in sharks’ blood to prevent dehydration, while also make their antibodies much more robust than that of other vertebrates. Comparing with the various immunoglobulin isotypes produced by other species, sharks, on the other hand, mainly produce IgM, IgW and IgNAR (immunoglobulin new antigen receptor). IgNAR is a heavy chain homodimer, which consists of five constant domains and one variable region (VNAR) for each heavy chain.

http://www.creative-biolabs.com/Monoclonal-Shark-Antibody-Production.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>igy antibody by Creative Biolabs</title><link>https://www.spreaker.com/user/9880356/igy-antibody-by-creative-biolabs</link><description><![CDATA[Creative Biolabs together with partners who are leading scientists in monoclonal chicken IgY antibody field offers the most recognized custom monoclonal chicken IgY antibody production services. Chicken IgY antibodies are avian equivalents of mammalian IgG antibodies. Compared to mammalian IgG antibodies, chicken IgY antibodies have higher avidity, less cross-reactivity and higher specificity, rendering chicken IgY antibodies more valuable in laboratory experiments and diagnostic assays.<br /><br /><a href="http://www.creative-biolabs.com/igY-antibody-generation.html" rel="noopener">http://www.creative-biolabs.com/igY-antibody-generation.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12319277</guid><pubDate>Mon, 10 Jul 2017 10:06:07 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12319277/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Creative Biolabs together with partners who are leading scientists in monoclonal chicken IgY antibody field offers the most recognized custom monoclonal chicken IgY antibody production services. Chicken IgY antibodies are avian equivalents of...</itunes:subtitle><itunes:summary><![CDATA[Creative Biolabs together with partners who are leading scientists in monoclonal chicken IgY antibody field offers the most recognized custom monoclonal chicken IgY antibody production services. Chicken IgY antibodies are avian equivalents of mammalian IgG antibodies. Compared to mammalian IgG antibodies, chicken IgY antibodies have higher avidity, less cross-reactivity and higher specificity, rendering chicken IgY antibodies more valuable in laboratory experiments and diagnostic assays.<br /><br /><a href="http://www.creative-biolabs.com/igY-antibody-generation.html" rel="noopener">http://www.creative-biolabs.com/igY-antibody-generation.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Creative Biolabs together with partners who are leading scientists in monoclonal chicken IgY antibody field offers the most recognized custom monoclonal chicken IgY antibody production services. Chicken IgY antibodies are avian equivalents of mammalian IgG antibodies. Compared to mammalian IgG antibodies, chicken IgY antibodies have higher avidity, less cross-reactivity and higher specificity, rendering chicken IgY antibodies more valuable in laboratory experiments and diagnostic assays.

http://www.creative-biolabs.com/igY-antibody-generation.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>rabbit human hybrid</title><link>https://www.spreaker.com/user/9880356/rabbit-human-hybrid</link><description><![CDATA[In contrast to rabbit hybridoma technology available in other leading companies, Creative Biolabs has built up a unique rabbit monoclonal antibody production platform based on our unparalleled expertise in phage display antibody library technology. We generate rabbit antibody libraries and select high affinity antigen-specific antibodies by phage display following Dr. Christoph Rader's methodology. <br /><br /><a href="http://www.creative-biolabs.com/production-of-monoclonal-rabbit-antibody.html" rel="noopener">http://www.creative-biolabs.com/production-of-monoclonal-rabbit-antibody.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12319203</guid><pubDate>Mon, 10 Jul 2017 09:50:08 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12319203/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>In contrast to rabbit hybridoma technology available in other leading companies, Creative Biolabs has built up a unique rabbit monoclonal antibody production platform based on our unparalleled expertise in phage display antibody library technology. We...</itunes:subtitle><itunes:summary><![CDATA[In contrast to rabbit hybridoma technology available in other leading companies, Creative Biolabs has built up a unique rabbit monoclonal antibody production platform based on our unparalleled expertise in phage display antibody library technology. We generate rabbit antibody libraries and select high affinity antigen-specific antibodies by phage display following Dr. Christoph Rader's methodology. <br /><br /><a href="http://www.creative-biolabs.com/production-of-monoclonal-rabbit-antibody.html" rel="noopener">http://www.creative-biolabs.com/production-of-monoclonal-rabbit-antibody.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>In contrast to rabbit hybridoma technology available in other leading companies, Creative Biolabs has built up a unique rabbit monoclonal antibody production platform based on our unparalleled expertise in phage display antibody library technology. We generate rabbit antibody libraries and select high affinity antigen-specific antibodies by phage display following Dr. Christoph Rader's methodology. 

http://www.creative-biolabs.com/production-of-monoclonal-rabbit-antibody.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>t cell production</title><link>https://www.spreaker.com/user/9880356/susansolomon-2012g</link><description><![CDATA[In 95% of T cells, this consists of an α and β chain, whereas in 5% of T cells this consists of γ and δ chains. This ratio changes during ontogeny and in diseased states. So the idiotype of each V region of a single immunoglobulin molecule may be comprised of as many as 15–20 idiotopes, which can be distinguished by monoclonal anti-idiotypic antibodies or defined by a specific and unique amino acid sequence. <a href="http://www.creative-biolabs.com/anti-idiotypic-antibodies-production-service-detecting-t-cell-receptors.html" rel="noopener">http://www.creative-biolabs.com/anti-idiotypic-antibodies-production-service-detecting-t-cell-receptors.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12319150</guid><pubDate>Mon, 10 Jul 2017 09:35:27 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12319150/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>In 95% of T cells, this consists of an α and β chain, whereas in 5% of T cells this consists of γ and δ chains. This ratio changes during ontogeny and in diseased states. So the idiotype of each V region of a single immunoglobulin molecule may be...</itunes:subtitle><itunes:summary><![CDATA[In 95% of T cells, this consists of an α and β chain, whereas in 5% of T cells this consists of γ and δ chains. This ratio changes during ontogeny and in diseased states. So the idiotype of each V region of a single immunoglobulin molecule may be comprised of as many as 15–20 idiotopes, which can be distinguished by monoclonal anti-idiotypic antibodies or defined by a specific and unique amino acid sequence. <a href="http://www.creative-biolabs.com/anti-idiotypic-antibodies-production-service-detecting-t-cell-receptors.html" rel="noopener">http://www.creative-biolabs.com/anti-idiotypic-antibodies-production-service-detecting-t-cell-receptors.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>In 95% of T cells, this consists of an α and β chain, whereas in 5% of T cells this consists of γ and δ chains. This ratio changes during ontogeny and in diseased states. So the idiotype of each V region of a single immunoglobulin molecule may be comprised of as many as 15–20 idiotopes, which can be distinguished by monoclonal anti-idiotypic antibodies or defined by a specific and unique amino acid sequence. http://www.creative-biolabs.com/anti-idiotypic-antibodies-production-service-detecting-t-cell-receptors.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>human monoclonal antibody by Creative Biolabs</title><link>https://www.spreaker.com/user/9880356/human-monoclonal-antibody-by-creative-bi</link><description><![CDATA[The mouse monoclonal antibodies are widely used for therapeutics and pathology researches, but may sometime be limited to their specificity and affinity.<br /><br /><a href="http://www.creative-biolabs.com/Native-TM-Mouse-Antibody-Discovery-Service.html" rel="noopener">http://www.creative-biolabs.com/Native-TM-Mouse-Antibody-Discovery-Service.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12319115</guid><pubDate>Mon, 10 Jul 2017 09:22:16 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12319115/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>The mouse monoclonal antibodies are widely used for therapeutics and pathology researches, but may sometime be limited to their specificity and affinity.

http://www.creative-biolabs.com/Native-TM-Mouse-Antibody-Discovery-Service.html</itunes:subtitle><itunes:summary><![CDATA[The mouse monoclonal antibodies are widely used for therapeutics and pathology researches, but may sometime be limited to their specificity and affinity.<br /><br /><a href="http://www.creative-biolabs.com/Native-TM-Mouse-Antibody-Discovery-Service.html" rel="noopener">http://www.creative-biolabs.com/Native-TM-Mouse-Antibody-Discovery-Service.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>The mouse monoclonal antibodies are widely used for therapeutics and pathology researches, but may sometime be limited to their specificity and affinity.

http://www.creative-biolabs.com/Native-TM-Mouse-Antibody-Discovery-Service.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>cdr3</title><link>https://www.spreaker.com/user/9880356/cdr3</link><description><![CDATA[By merging the ultralong CDR3s discovered in bovine with human IgG scaffolds, novel therapeutic antibodies against challenging hot antigen families, including GPCRs and other intra-membrane targets on the cell surface are possible. Humanized IgG scaffolds that accommodate ultralong CDR3s may target small proteins with desirable therapeutic properties, which are challenging for conventional antibodies.<br /><br /><a href="http://www.creative-biolabs.com/Humanization-of-Bovine-Ultralong-CDR3-Antibodies.html" rel="noopener">http://www.creative-biolabs.com/Humanization-of-Bovine-Ultralong-CDR3-Antibodies.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12319077</guid><pubDate>Mon, 10 Jul 2017 09:06:25 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12319077/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>By merging the ultralong CDR3s discovered in bovine with human IgG scaffolds, novel therapeutic antibodies against challenging hot antigen families, including GPCRs and other intra-membrane targets on the cell surface are possible. Humanized IgG...</itunes:subtitle><itunes:summary><![CDATA[By merging the ultralong CDR3s discovered in bovine with human IgG scaffolds, novel therapeutic antibodies against challenging hot antigen families, including GPCRs and other intra-membrane targets on the cell surface are possible. Humanized IgG scaffolds that accommodate ultralong CDR3s may target small proteins with desirable therapeutic properties, which are challenging for conventional antibodies.<br /><br /><a href="http://www.creative-biolabs.com/Humanization-of-Bovine-Ultralong-CDR3-Antibodies.html" rel="noopener">http://www.creative-biolabs.com/Humanization-of-Bovine-Ultralong-CDR3-Antibodies.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>By merging the ultralong CDR3s discovered in bovine with human IgG scaffolds, novel therapeutic antibodies against challenging hot antigen families, including GPCRs and other intra-membrane targets on the cell surface are possible. Humanized IgG scaffolds that accommodate ultralong CDR3s may target small proteins with desirable therapeutic properties, which are challenging for conventional antibodies.

http://www.creative-biolabs.com/Humanization-of-Bovine-Ultralong-CDR3-Antibodies.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>antibody expression</title><link>https://www.spreaker.com/user/9880356/antibody-expression</link><description><![CDATA[• Construction of chimeric antibody expression vectors <br />The gene of a scFv or Fab antibody obtained from phage display technology or amplified from a mouse/rat hybridoma cell line is cloned into our proprietary mammalian expression vectors that contain the constant regions of human or mouse IgG light chain and heavy chain. <br /><br /><a href="http://www.creative-biolabs.com/recombinant-igG-production.html" rel="noopener">http://www.creative-biolabs.com/recombinant-igG-production.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12318888</guid><pubDate>Mon, 10 Jul 2017 07:58:48 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12318888/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>• Construction of chimeric antibody expression vectors 
The gene of a scFv or Fab antibody obtained from phage display technology or amplified from a mouse/rat hybridoma cell line is cloned into our proprietary mammalian expression vectors that...</itunes:subtitle><itunes:summary><![CDATA[• Construction of chimeric antibody expression vectors <br />The gene of a scFv or Fab antibody obtained from phage display technology or amplified from a mouse/rat hybridoma cell line is cloned into our proprietary mammalian expression vectors that contain the constant regions of human or mouse IgG light chain and heavy chain. <br /><br /><a href="http://www.creative-biolabs.com/recombinant-igG-production.html" rel="noopener">http://www.creative-biolabs.com/recombinant-igG-production.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotech</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>• Construction of chimeric antibody expression vectors 
The gene of a scFv or Fab antibody obtained from phage display technology or amplified from a mouse/rat hybridoma cell line is cloned into our proprietary mammalian expression vectors that contain the constant regions of human or mouse IgG light chain and heavy chain. 

http://www.creative-biolabs.com/recombinant-igG-production.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>ferret antibodies</title><link>https://www.spreaker.com/user/9880356/ferret-antibodies</link><description><![CDATA[Ferret (Mustela putorius furo) is a kind of domestic animals belong to the family Mustelidae (also includes weasel, otter and mink). In biological research, ferret is well recognized as the indispensable mammalian model in the investigation of influenza viruses. Because of their relatively small size, similar lung physiology with human and other clinical features associated with human diseases, ferret is obviously an attractive species for the studies related to virus-host interactions. <a href="http://www.creative-biolabs.com/native-ferret-antibody-discovery-service.html" rel="noopener">http://www.creative-biolabs.com/native-ferret-antibody-discovery-service.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12061124</guid><pubDate>Thu, 08 Jun 2017 03:35:45 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12061124/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Ferret (Mustela putorius furo) is a kind of domestic animals belong to the family Mustelidae (also includes weasel, otter and mink). In biological research, ferret is well recognized as the indispensable mammalian model in the investigation of...</itunes:subtitle><itunes:summary><![CDATA[Ferret (Mustela putorius furo) is a kind of domestic animals belong to the family Mustelidae (also includes weasel, otter and mink). In biological research, ferret is well recognized as the indispensable mammalian model in the investigation of influenza viruses. Because of their relatively small size, similar lung physiology with human and other clinical features associated with human diseases, ferret is obviously an attractive species for the studies related to virus-host interactions. <a href="http://www.creative-biolabs.com/native-ferret-antibody-discovery-service.html" rel="noopener">http://www.creative-biolabs.com/native-ferret-antibody-discovery-service.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Ferret (Mustela putorius furo) is a kind of domestic animals belong to the family Mustelidae (also includes weasel, otter and mink). In biological research, ferret is well recognized as the indispensable mammalian model in the investigation of influenza viruses. Because of their relatively small size, similar lung physiology with human and other clinical features associated with human diseases, ferret is obviously an attractive species for the studies related to virus-host interactions. http://www.creative-biolabs.com/native-ferret-antibody-discovery-service.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>octet system</title><link>https://www.spreaker.com/user/9880356/octet-system</link><description><![CDATA[Key Features of Octet system:<br />Label-free and real-time assay.<br />High throughput: up to 384 samples can be analyzed simultaneously without frequent surface regeneration.<br />Crude sample compatibility: Protein can be assayed in crude mixture got directly from bioreactors or periplasmic preparations without interference.<br /><br /><a href="http://www.creative-biolabs.com/Octet-system.html" rel="noopener">http://www.creative-biolabs.com/Octet-system.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12061121</guid><pubDate>Thu, 08 Jun 2017 03:34:36 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12061121/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Key Features of Octet system:
Label-free and real-time assay.
High throughput: up to 384 samples can be analyzed simultaneously without frequent surface regeneration.
Crude sample compatibility: Protein can be assayed in crude mixture got directly...</itunes:subtitle><itunes:summary><![CDATA[Key Features of Octet system:<br />Label-free and real-time assay.<br />High throughput: up to 384 samples can be analyzed simultaneously without frequent surface regeneration.<br />Crude sample compatibility: Protein can be assayed in crude mixture got directly from bioreactors or periplasmic preparations without interference.<br /><br /><a href="http://www.creative-biolabs.com/Octet-system.html" rel="noopener">http://www.creative-biolabs.com/Octet-system.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Key Features of Octet system:
Label-free and real-time assay.
High throughput: up to 384 samples can be analyzed simultaneously without frequent surface regeneration.
Crude sample compatibility: Protein can be assayed in crude mixture got directly from bioreactors or periplasmic preparations without interference.

http://www.creative-biolabs.com/Octet-system.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>Oxidation</title><link>https://www.spreaker.com/user/9880356/oxidation</link><description><![CDATA[Methionine and Tryptophan, to a weaker extent, are more susceptible to oxidation in non-site specific reaction. Methionine is dominantly sensitive to free ROS and Tryptophan to light induced oxidation. The extent of sensitivity lies on the solvent accessibility of the side chain and residues buried in the protein core are relatively less sensitive or need longer to react. Antibody oxidation can occur during antibody production, purification, formulation or storage and influence the biological activity and stability. <a href="http://www.creative-biolabs.com/Oxidation.htm" rel="noopener">http://www.creative-biolabs.com/Oxidation.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12061119</guid><pubDate>Thu, 08 Jun 2017 03:32:58 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12061119/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Methionine and Tryptophan, to a weaker extent, are more susceptible to oxidation in non-site specific reaction. Methionine is dominantly sensitive to free ROS and Tryptophan to light induced oxidation. The extent of sensitivity lies on the solvent...</itunes:subtitle><itunes:summary><![CDATA[Methionine and Tryptophan, to a weaker extent, are more susceptible to oxidation in non-site specific reaction. Methionine is dominantly sensitive to free ROS and Tryptophan to light induced oxidation. The extent of sensitivity lies on the solvent accessibility of the side chain and residues buried in the protein core are relatively less sensitive or need longer to react. Antibody oxidation can occur during antibody production, purification, formulation or storage and influence the biological activity and stability. <a href="http://www.creative-biolabs.com/Oxidation.htm" rel="noopener">http://www.creative-biolabs.com/Oxidation.htm</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Methionine and Tryptophan, to a weaker extent, are more susceptible to oxidation in non-site specific reaction. Methionine is dominantly sensitive to free ROS and Tryptophan to light induced oxidation. The extent of sensitivity lies on the solvent accessibility of the side chain and residues buried in the protein core are relatively less sensitive or need longer to react. Antibody oxidation can occur during antibody production, purification, formulation or storage and influence the biological activity and stability. http://www.creative-biolabs.com/Oxidation.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>scfv purification</title><link>https://www.spreaker.com/user/9880356/scfv-purification</link><description><![CDATA[If a monoclonal antibody is available, the Fab fragment can be created enzymatically. papain is a cysteine protease enzyme that has the endopeptidase activity to cleave immunoglobulin G molecules in the hinge reason. This cleavage results in the generation of three ~50kDa fragments, two Fab domains and a Fc domain. The papain-digested antibody is unable to promote agglutination, precipitation, opsonization, and lysis. Immobilized papain offers the advantage of generating Fab and Fc fragments without the need to remove the papain enzyme after digestion. <a href="http://www.creative-biolabs.com/scfv-fab-generation.html" rel="noopener">http://www.creative-biolabs.com/scfv-fab-generation.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12061107</guid><pubDate>Thu, 08 Jun 2017 03:30:45 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12061107/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>If a monoclonal antibody is available, the Fab fragment can be created enzymatically. papain is a cysteine protease enzyme that has the endopeptidase activity to cleave immunoglobulin G molecules in the hinge reason. This cleavage results in the...</itunes:subtitle><itunes:summary><![CDATA[If a monoclonal antibody is available, the Fab fragment can be created enzymatically. papain is a cysteine protease enzyme that has the endopeptidase activity to cleave immunoglobulin G molecules in the hinge reason. This cleavage results in the generation of three ~50kDa fragments, two Fab domains and a Fc domain. The papain-digested antibody is unable to promote agglutination, precipitation, opsonization, and lysis. Immobilized papain offers the advantage of generating Fab and Fc fragments without the need to remove the papain enzyme after digestion. <a href="http://www.creative-biolabs.com/scfv-fab-generation.html" rel="noopener">http://www.creative-biolabs.com/scfv-fab-generation.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>biology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>If a monoclonal antibody is available, the Fab fragment can be created enzymatically. papain is a cysteine protease enzyme that has the endopeptidase activity to cleave immunoglobulin G molecules in the hinge reason. This cleavage results in the generation of three ~50kDa fragments, two Fab domains and a Fc domain. The papain-digested antibody is unable to promote agglutination, precipitation, opsonization, and lysis. Immobilized papain offers the advantage of generating Fab and Fc fragments without the need to remove the papain enzyme after digestion. http://www.creative-biolabs.com/scfv-fab-generation.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>neddylation</title><link>https://www.spreaker.com/user/9880356/neddylation</link><description><![CDATA[Neddylation is a process by which the ubiquitin-like protein NEDD8 (neural-precursor-cell-expressed developmentally down-regulated 8) is conjugated to its target proteins. This process includes NEDD8 precursor processing, activation by the E1 (UBA3-APPBP1 heterodimer), loading onto the E2 (Ubc12), conjugation to a substrate by an E3 and recycling of NEDD8 by an isopeptidase, which is analogous to ubiquitination. In contrast to the ubiquitination, the neddylation does not target proteins for degradation, rather acts on only a few substrates. <a href="http://www.creative-biolabs.com/Neddylation-Specific-Antibody-Production-Service.html" rel="noopener">http://www.creative-biolabs.com/Neddylation-Specific-Antibody-Production-Service.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12061052</guid><pubDate>Thu, 08 Jun 2017 03:20:01 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12061052/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Bella Smith</itunes:author><itunes:subtitle>Neddylation is a process by which the ubiquitin-like protein NEDD8 (neural-precursor-cell-expressed developmentally down-regulated 8) is conjugated to its target proteins. This process includes NEDD8 precursor processing, activation by the E1...</itunes:subtitle><itunes:summary><![CDATA[Neddylation is a process by which the ubiquitin-like protein NEDD8 (neural-precursor-cell-expressed developmentally down-regulated 8) is conjugated to its target proteins. This process includes NEDD8 precursor processing, activation by the E1 (UBA3-APPBP1 heterodimer), loading onto the E2 (Ubc12), conjugation to a substrate by an E3 and recycling of NEDD8 by an isopeptidase, which is analogous to ubiquitination. In contrast to the ubiquitination, the neddylation does not target proteins for degradation, rather acts on only a few substrates. <a href="http://www.creative-biolabs.com/Neddylation-Specific-Antibody-Production-Service.html" rel="noopener">http://www.creative-biolabs.com/Neddylation-Specific-Antibody-Production-Service.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--3wAJlYvu--/w_1000,h_800,c_fit,l_text:Lato_162_bold:Bella%20Smith%20s%20show/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Bella Smith</googleplay:author><googleplay:description>Neddylation is a process by which the ubiquitin-like protein NEDD8 (neural-precursor-cell-expressed developmentally down-regulated 8) is conjugated to its target proteins. This process includes NEDD8 precursor processing, activation by the E1 (UBA3-APPBP1 heterodimer), loading onto the E2 (Ubc12), conjugation to a substrate by an E3 and recycling of NEDD8 by an isopeptidase, which is analogous to ubiquitination. In contrast to the ubiquitination, the neddylation does not target proteins for degradation, rather acts on only a few substrates. http://www.creative-biolabs.com/Neddylation-Specific-Antibody-Production-Service.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item></channel></rss>
